相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort
Leah C. Katzelnick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Dengue infection
Maria G. Guzman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies
Wen-Yang Tsai et al.
JOURNAL OF VIROLOGY (2015)
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
Guntur Fibriansah et al.
NATURE COMMUNICATIONS (2015)
Preexisting Neutralizing Antibody Responses Distinguish Clinically Inapparent and Apparent Dengue Virus Infections in a Sri Lankan Pediatric Cohort
Kizzmekia S. Corbett et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
Wanwisa Dejnirattisai et al.
NATURE IMMUNOLOGY (2015)
Isolation of Dengue Virus-Specific Memory B Cells with Live Virus Antigen from Human Subjects following Natural Infection Reveals the Presence of Diverse Novel Functional Groups of Antibody Clones
Scott A. Smith et al.
JOURNAL OF VIROLOGY (2014)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection
Wen-Yang Tsai et al.
JOURNAL OF VIROLOGY (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
Magelda Montoya et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
CURRENT CONCEPTS Dengue
Cameron P. Simmons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Dominant Cross-Reactive B Cell Response during Secondary Acute Dengue Virus Infection in Humans
Simona Zompi et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Immune Response to Dengue Virus and Prospects for a Vaccine
Brian R. Murphy et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
Martina Beltramello et al.
CELL HOST & MICROBE (2010)
Trends in Patterns of Dengue Transmission over 4 Years in a Pediatric Cohort Study in Nicaragua
Angel Balmaseda et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
John S. Schieffelin et al.
VIROLOGY JOURNAL (2010)
The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases
Guillermina Kuan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
W. M. P. B. Wahala et al.
VIROLOGY (2009)
Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II
Chih-Yun Lai et al.
JOURNAL OF VIROLOGY (2008)
Antibody to dengue 1 detected more than 6 years after infection
Allison Imrie et al.
VIRAL IMMUNOLOGY (2007)
Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization
Annette A. Kraus et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Sensitivity and specificity of three ELISA-based assays for discriminating primary from secondary acute dengue virus infection
Vanda Akico Ueda Fick de Souza et al.
JOURNAL OF CLINICAL VIROLOGY (2007)
Discrimination between primary and secondary Dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample
S Matheus et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)